Q4 2024 Holdings
Filed 2025-02-14 | 38 holdings | $1.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CG Oncology Inc(CGON) | COMM | 156944100 | $105.3M | 3,670,206 | 10.3% |
| Dyne Therapeutics Inc(DYN) | COMM | 26818M108 | $62.4M | 2,650,150 | 6.1% |
| Xencor Inc(XNCR) | COMM | 98401F105 | $56.4M | 2,452,138 | 5.5% |
| Cogent Biosciences Inc(COGT) | COMM | 19240Q201 | $54.3M | 6,964,375 | 5.3% |
| Centessa Pharmaceuticals PLC(CNTA) | ADRS | 152309100 | $48.4M | 2,890,816 | 4.7% |
| Ocular Therapeutix Inc(OCUL) | COMM | 67576A100 | $45.4M | 5,319,148 | 4.4% |
| Upstream BIO Inc(UPB) | COMM | 91678A107 | $44.9M | 2,801,763 | 4.4% |
| Abivax SA American Depositary Shares(ABVX) | ADRS | 00370M103 | $44.3M | 6,056,596 | 4.3% |
| Savara Inc(SVRA) | COMM | 805111101 | $38.0M | 12,362,205 | 3.7% |
| Tango Therapeutics Inc(TNGX) | COMM | 87583X109 | $33.2M | 10,736,000 | 3.2% |
| Dianthus Therapeutics Inc(DNTH) | COMM | 252828108 | $32.7M | 1,501,624 | 3.2% |
| Disc Medicine Inc(IRON) | COMM | 254604101 | $30.9M | 486,957 | 3.0% |
| Mineralys Therapeutics Inc(MLYS) | COMM | 603170101 | $30.4M | 2,470,265 | 3.0% |
| Tourmaline BIO Inc(TRML) | COMM | 89157D105 | $30.0M | 1,477,593 | 2.9% |
| Structure Therapeutics Inc(GPCR) | ADRS | 86366E106 | $28.8M | 1,063,000 | 2.8% |
| Tyra Biosciences Inc(TYRA) | COMM | 90240B106 | $27.6M | 1,989,103 | 2.7% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COMM | 30233G209 | $26.6M | 3,572,335 | 2.6% |
| Cidara Therapeutics, Inc.(CDTX) | COMM | 171757206 | $26.1M | 1,005,901 | 2.5% |
| Third Harmonic BIO Inc(THRD) | COMM | 88427A107 | $25.8M | 2,505,424 | 2.5% |
| Soleno Therapeutics Inc(SLNO) | COMM | 834203309 | $24.7M | 550,000 | 2.4% |
| Astria Therapeutics Inc(CATBUSD) | COMM | 04635X102 | $24.7M | 2,761,861 | 2.4% |
| Fulcrum Therapeutics Inc(FULC) | COMM | 359616109 | $24.7M | 5,250,000 | 2.4% |
| Silence Therapeutics PLC(SLN) | ADRS | 82686Q101 | $20.9M | 3,033,560 | 2.0% |
| Rapt Therapeutics, Inc.(RAPTEUR) | COMM | 75382E109 | $19.8M | 13,135,260 | 1.9% |
| Amylyx Pharmaceuticals Inc(AMLX) | COMM | 03237H101 | $17.6M | 4,643,812 | 1.7% |
| Compass Pathways LTD(CMPS) | ADRS | 20451W101 | $14.6M | 3,858,000 | 1.4% |
| Kura Oncology Inc(KURA) | COMM | 50127T109 | $12.4M | 1,423,642 | 1.2% |
| MBX Biosciences Inc(MBX) | COMM | 55287L101 | $12.0M | 650,000 | 1.2% |
| Kodiak Sciences Inc(KOD) | COMM | 50015M109 | $11.4M | 1,145,538 | 1.1% |
| Entrada Therapeutics Inc(TRDA) | COMM | 29384C108 | $10.1M | 584,955 | 1.0% |
| Keros Therapeutics Inc(KROS) | COMM | 492327101 | $8.7M | 550,000 | 0.9% |
| Adverum Biotechnologies Inc(AVU0) | COMM | 00773U207 | $8.4M | 1,796,482 | 0.8% |
| Vistagen Therapeutics Inc(VTGN) | COMM | 92840H400 | $7.9M | 2,676,580 | 0.8% |
| Aerovate Therapeutics Inc | COMM | 008064107 | $5.9M | 2,240,809 | 0.6% |
| Nektar Therapeutics(NKTREUR) | COMM | 640268108 | $3.7M | 4,000,000 | 0.4% |
| Avalo Therapeutics Inc(AVTX) | COMM | 05338F306 | $3.6M | 483,000 | 0.4% |
| Ventyx Biosciences Inc(VTYX) | COMM | 92332V107 | $692.5K | 316,195 | 0.1% |
| Cabaletta BIO Inc(CABA) | COMM | 12674W109 | $197.0K | 86,795 | 0.0% |